Details for Phosphorylated IGFBP-1 as a non-invasive predictor of liver fat in NAFLD

PropertyValue
Name:Phosphorylated IGFBP-1 as a non-invasive predictor of liver fat in NAFLD
Description:

Insulin-like growth factor binding protein 1 (IGFBP-1) is a potentially interesting marker for liver fat in NAFLD as it is exclusively produced by the liver, and insulin is its main regulator. We determined whether measurement of fasting serum phosphorylated IGFBP-1 (fS-pIGFBP-1) helps to predict liver fat compared to routinely available clinical parameters and PNPLA3 genotype at rs738409. Liver fat content (proton magnetic resonance spectroscopy) was measured in 378 subjects (62% women, age 43 [30–54] years, BMI 32.7 [28.1–39.7] kg/m2, 46% with NAFLD). Subjects were randomized to discovery and validation groups, which were matched for clinical and biochemical parameters and PNPLA3 genotype. Multiple linear regression and Random Forest modeling were used to identify predictors of liver fat. The final model, % Liver Fat Equation’, included age, fS-pIGFBP-1, S-ALT, waist-to-hip ratio, fP-Glucose and fS-Insulin (adjusted R2 = 0.44 in the discovery group, 0.49 in the validation group, 0.47 in all subjects). The model was significantly better than a model without fS-pIGFBP-1 or S-ALT or S-AST alone. Random Forest modeling identified fS-p-IGFBP-1 as one of the top five predictors of liver fat (adjusted R2 = 0.39). Therefore, measurement of fS-pIGFBP-1 may help in non-invasive prediction of liver fat content.

Authors:Petäjä, E.M. et al.
Journal Title:Scientific Reports
Journal Year:2016
Volume / Issue No.:6, 24740
Digital Object Identifier:http://dx.doi.org/10.1038/srep24740
Filename:Petaja_Scientific Reports_2016.pdf
Filesize: 505.25 kB
Filetype:pdf (Mime Type: application/pdf)
Creator:ixscient
Created On: 01/10/2017 22:30
Viewers:Everybody
Maintained by:ixscient
Hits:337 Hits
Last updated on: 01/10/2017 22:38
Homepage:
CRC Checksum:
MD5 Checksum: